Surgery Partners (SGRY) Stock Forecast, Price Target & Predictions
SGRY Stock Forecast
Surgery Partners stock forecast is as follows: an average price target of $35.00 (represents a 64.94% upside from SGRY’s last price of $21.22) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
SGRY Price Target
The average price target for Surgery Partners (SGRY) is $35.00 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $40.00 to $31.00. This represents a potential 64.94% upside from SGRY's last price of $21.22.
SGRY Analyst Ratings
According to 11 Wall Street analysts, Surgery Partners's rating consensus is 'Buy'. The analyst rating breakdown for SGRY stock is 0 'Strong Buy' (0.00%), 7 'Buy' (63.64%), 4 'Hold' (36.36%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Surgery Partners Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 13, 2024 | Brian Tanquilut | Jefferies | $40.00 | $29.74 | 34.50% | 88.50% |
| Nov 13, 2024 | Andrew Mok | Barclays | $31.00 | $29.74 | 4.24% | 46.09% |
| Oct 14, 2024 | AJ Rice | UBS | $38.00 | $30.46 | 24.75% | 79.08% |
| Jun 28, 2024 | Tao Qiu | Macquarie | $31.00 | $24.32 | 27.47% | 46.09% |
| May 04, 2022 | Citigroup | $64.00 | $53.62 | 19.37% | 201.60% |
The latest Surgery Partners stock forecast, released on Nov 13, 2024 by Brian Tanquilut from Jefferies, set a price target of $40.00, which represents a 34.50% increase from the stock price at the time of the forecast ($29.74), and a 88.50% increase from SGRY last price ($21.22).
Surgery Partners Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 3 | 4 |
| Avg Price Target | - | $36.33 | $35.00 |
| Last Closing Price | $21.22 | $21.22 | $21.22 |
| Upside/Downside | -100.00% | 71.21% | 64.94% |
In the current month, the average price target of Surgery Partners stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Surgery Partners's last price of $21.22. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 14, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Nov 13, 2024 | Jefferies | Buy | Buy | Hold |
| Oct 14, 2024 | UBS | Buy | Initialise | |
| Oct 10, 2024 | KeyBanc | Sector Weight | Initialise | |
| Oct 04, 2024 | RBC Capital | Buy | Buy | Hold |
| Aug 19, 2024 | Raymond James | Underperform | Underperform | Hold |
| Aug 19, 2024 | RBC Capital | Buy | Buy | Hold |
| Jun 28, 2024 | Macquarie | Buy | Buy | Hold |
| Jun 28, 2024 | Macquarie | Outperform | Initialise | |
| Mar 05, 2024 | RBC Capital | Buy | Buy | Hold |
| Nov 14, 2023 | Cowen & Co. | Outperform | Upgrade | |
| Jun 02, 2023 | Goldman Sachs | Neutral | Downgrade | |
| Jun 02, 2023 | BMO Capital | Outperform | Upgrade | |
| Jun 02, 2023 | Atlantic Equities | Neutral | Downgrade | |
| Jun 02, 2023 | BTIG | Neutral | Downgrade | |
| Jun 02, 2023 | Bank of America Securities | Buy | Upgrade |
Surgery Partners's last stock rating was published by Cowen & Co. on Nov 14, 2024. The company gave SGRY a "Buy" rating, the same as its previous rate.
Surgery Partners Financial Forecast
Surgery Partners Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $735.40M | $674.10M | $667.60M | $666.20M | $707.10M | $620.60M | $615.40M | $596.20M | $610.20M | $559.20M | $543.30M | $512.40M | $548.30M | $496.10M | $374.70M | $441.00M | $517.20M | $452.00M |
| Avg Forecast | $980.90M | $939.66M | $912.07M | $881.71M | $901.70M | $850.63M | $833.51M | $803.83M | $828.12M | $768.99M | $735.94M | $698.73M | $741.45M | $671.99M | $669.43M | $656.74M | $688.06M | $633.99M | $623.90M | $576.58M | $624.38M | $543.03M | $533.43M | $494.74M | $548.64M | $462.15M | $302.26M | $405.09M | $514.93M | $452.12M |
| High Forecast | $999.79M | $957.75M | $929.63M | $898.68M | $919.06M | $867.01M | $849.56M | $823.31M | $833.48M | $770.12M | $735.94M | $698.83M | $743.58M | $671.99M | $682.32M | $669.38M | $701.30M | $633.99M | $623.90M | $576.58M | $624.38M | $543.03M | $533.43M | $494.74M | $548.64M | $462.15M | $302.26M | $405.09M | $514.93M | $452.12M |
| Low Forecast | $963.97M | $923.44M | $896.33M | $866.49M | $886.13M | $835.95M | $819.13M | $782.85M | $824.22M | $767.85M | $735.94M | $698.63M | $737.22M | $671.99M | $657.88M | $645.40M | $676.18M | $633.99M | $623.90M | $576.58M | $624.38M | $543.03M | $533.43M | $494.74M | $548.64M | $462.15M | $302.26M | $405.09M | $514.93M | $452.12M |
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 8 | 4 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 10 | 16 | 8 | 11 | 7 | 11 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 1.00% | 1.00% | 1.01% | 1.03% | 0.98% | 0.99% | 1.03% | 0.98% | 1.03% | 1.02% | 1.04% | 1.00% | 1.07% | 1.24% | 1.09% | 1.00% | 1.00% |
Surgery Partners's average Quarter revenue forecast for Mar 24 based on 4 analysts is $698.73M, with a low forecast of $698.63M, and a high forecast of $698.83M. SGRY's average Quarter revenue forecast represents a -4.99% decrease compared to the company's last Quarter revenue of $735.40M (Dec 23).
Surgery Partners EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 8 | 4 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 10 | 16 | 8 | 11 | 7 | 11 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $35.10M | $11.90M | $26.60M | $106.10M | $169.80M | $118.60M | $113.80M | $102.00M | $71.82M | $57.70M | $49.00M | $58.20M | $79.40M | $15.30M | $39.50M | $26.20M | $21.40M | $79.60M |
| Avg Forecast | $170.63M | $163.46M | $158.66M | $153.38M | $156.85M | $147.97M | $144.99M | $139.83M | $144.06M | $133.77M | $128.02M | $69.13M | $128.98M | $116.90M | $116.45M | $62.84M | $62.37M | $122.40M | $120.45M | $57.13M | $120.54M | $104.84M | $102.98M | $69.21M | $105.92M | $89.22M | $58.35M | $33.84M | $99.41M | $87.29M |
| High Forecast | $173.92M | $166.60M | $161.71M | $156.33M | $159.87M | $150.82M | $147.78M | $143.22M | $144.99M | $133.97M | $128.02M | $82.95M | $129.35M | $116.90M | $118.69M | $75.41M | $74.85M | $122.40M | $120.45M | $68.56M | $120.54M | $104.84M | $102.98M | $83.05M | $105.92M | $89.22M | $58.35M | $40.61M | $99.41M | $87.29M |
| Low Forecast | $167.69M | $160.64M | $155.92M | $150.73M | $154.15M | $145.42M | $142.49M | $136.18M | $143.38M | $133.57M | $128.02M | $55.30M | $128.24M | $116.90M | $114.44M | $50.28M | $49.90M | $122.40M | $120.45M | $45.71M | $120.54M | $104.84M | $102.98M | $55.37M | $105.92M | $89.22M | $58.35M | $27.07M | $99.41M | $87.29M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.27% | 0.10% | 0.23% | 1.69% | 2.72% | 0.97% | 0.94% | 1.79% | 0.60% | 0.55% | 0.48% | 0.84% | 0.75% | 0.17% | 0.68% | 0.77% | 0.22% | 0.91% |
4 analysts predict SGRY's average Quarter EBITDA for Mar 24 to be $69.13M, with a high of $82.95M and a low of $55.30M. This is 96.95% upper than Surgery Partners's previous annual EBITDA (Dec 23) of $35.10M.
Surgery Partners Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 8 | 4 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 10 | 16 | 8 | 11 | 7 | 11 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $58.70M | $35.90M | $42.10M | $1.20M | $23.30M | $5.60M | $15.30M | $42.80M | $42.90M | $-22.90M | $-26.90M | $-21.00M | $5.50M | $-61.60M | $-32.50M | $-27.50M | $-19.20M | $-15.70M |
| Avg Forecast | $73.50M | $41.60M | $29.00M | $15.63M | $63.54M | $33.49M | $23.28M | $11.28M | $46.86M | $31.74M | $25.17M | $12.08M | $47.77M | $18.06M | $10.20M | $10.98M | $-86.84K | $5.76M | $-2.44M | $9.98M | $24.45M | $-7.48M | $-19.78M | $-24.97M | $2.07M | $-47.74M | $-87.20M | $-35.52M | $15.65M | $-26.14M |
| High Forecast | $75.33M | $42.64M | $29.73M | $16.03M | $65.13M | $34.32M | $23.86M | $21.30M | $57.40M | $32.14M | $25.20M | $14.49M | $51.65M | $18.06M | $10.46M | $13.18M | $-69.47K | $5.76M | $-2.44M | $11.98M | $24.45M | $-7.48M | $-19.78M | $-19.98M | $2.07M | $-47.74M | $-87.20M | $-28.42M | $15.65M | $-26.14M |
| Low Forecast | $71.85M | $40.67M | $28.35M | $15.28M | $62.12M | $32.73M | $22.76M | $-1.25M | $36.31M | $31.33M | $25.14M | $9.66M | $43.90M | $18.05M | $9.97M | $8.78M | $-104.21K | $5.76M | $-2.44M | $7.99M | $24.45M | $-7.48M | $-19.78M | $-29.97M | $2.07M | $-47.74M | $-87.20M | $-42.62M | $15.65M | $-26.14M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.23% | 1.99% | 4.13% | 0.11% | -268.31% | 0.97% | -6.27% | 4.29% | 1.75% | 3.06% | 1.36% | 0.84% | 2.66% | 1.29% | 0.37% | 0.77% | -1.23% | 0.60% |
Surgery Partners's average Quarter net income forecast for Mar 24 is $12.08M, with a range of $9.66M to $14.49M. SGRY's average Quarter net income forecast represents a -79.42% decrease compared to the company's last Quarter net income of $58.70M (Dec 23).
Surgery Partners SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 8 | 4 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 10 | 16 | 8 | 11 | 7 | 11 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $97.80M | $109.20M | $104.10M | $32.00M | $28.70M | $17.90M | $26.10M | $29.50M | $27.20M | $25.50M | $24.50M | $26.80M | $23.80M | $25.20M | $25.30M | $43.10M | $42.90M | $38.30M |
| Avg Forecast | $45.44M | $43.53M | $42.25M | $40.85M | $41.77M | $39.41M | $38.61M | $37.24M | $38.36M | $35.63M | $34.09M | $92.17M | $34.35M | $31.13M | $31.01M | $83.79M | $23.62M | $29.37M | $28.90M | $76.17M | $28.93M | $25.16M | $24.71M | $31.87M | $25.42M | $21.41M | $14.00M | $55.67M | $23.86M | $20.95M |
| High Forecast | $46.32M | $44.37M | $43.07M | $41.63M | $42.58M | $40.17M | $39.36M | $38.14M | $38.61M | $35.68M | $34.09M | $110.60M | $34.45M | $31.13M | $31.61M | $100.55M | $28.35M | $29.37M | $28.90M | $91.41M | $28.93M | $25.16M | $24.71M | $38.24M | $25.42M | $21.41M | $14.00M | $66.80M | $23.86M | $20.95M |
| Low Forecast | $44.66M | $42.78M | $41.52M | $40.14M | $41.05M | $38.73M | $37.95M | $36.27M | $38.18M | $35.57M | $34.09M | $73.74M | $34.15M | $31.13M | $30.48M | $67.03M | $18.90M | $29.37M | $28.90M | $60.94M | $28.93M | $25.16M | $24.71M | $25.50M | $25.42M | $21.41M | $14.00M | $44.54M | $23.86M | $20.95M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.85% | 3.51% | 3.36% | 0.38% | 1.22% | 0.61% | 0.90% | 0.39% | 0.94% | 1.01% | 0.99% | 0.84% | 0.94% | 1.18% | 1.81% | 0.77% | 1.80% | 1.83% |
Surgery Partners's average Quarter SG&A projection for Mar 24 is $92.17M, based on 4 Wall Street analysts, with a range of $73.74M to $110.60M. The forecast indicates a -5.76% fall compared to SGRY last annual SG&A of $97.80M (Dec 23).
Surgery Partners EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 8 | 4 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 10 | 16 | 8 | 11 | 7 | 11 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.29 | - | $0.01 | $0.23 | $0.06 | $0.17 | $0.49 | $0.51 | $-0.28 | $-0.39 | $-0.38 | $0.11 | $-1.46 | $-0.86 | $-0.57 | $-0.40 | $-0.32 |
| Avg Forecast | $0.58 | $0.33 | $0.23 | $0.12 | $0.50 | $0.27 | $0.18 | $0.09 | $0.37 | $0.25 | $0.20 | $0.07 | $0.38 | $0.14 | $0.08 | - | $0.20 | $0.05 | $-0.02 | $-0.07 | $0.19 | $-0.06 | $-0.16 | $-0.37 | $0.02 | $-0.38 | $-0.69 | $-0.45 | $0.12 | $-0.21 |
| High Forecast | $0.60 | $0.34 | $0.24 | $0.13 | $0.52 | $0.27 | $0.19 | $0.17 | $0.45 | $0.25 | $0.20 | $0.07 | $0.41 | $0.14 | $0.08 | - | $0.21 | $0.05 | $-0.02 | $-0.07 | $0.19 | $-0.06 | $-0.16 | $-0.37 | $0.02 | $-0.38 | $-0.69 | $-0.45 | $0.12 | $-0.21 |
| Low Forecast | $0.57 | $0.32 | $0.22 | $0.12 | $0.49 | $0.26 | $0.18 | $-0.01 | $0.29 | $0.25 | $0.20 | $0.07 | $0.35 | $0.14 | $0.08 | - | $0.20 | $0.05 | $-0.02 | $-0.07 | $0.19 | $-0.06 | $-0.16 | $-0.37 | $0.02 | $-0.38 | $-0.69 | $-0.45 | $0.12 | $-0.21 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 2.03% | 0.00% | 2.61% | 1.13% | 1.38% | -8.78% | -6.91% | 2.63% | 4.72% | 2.49% | 1.03% | 6.85% | 3.86% | 1.24% | 1.27% | -3.20% | 1.57% |
According to 4 Wall Street analysts, Surgery Partners's projected average Quarter EPS for Mar 24 is $0.07, with a low estimate of $0.07 and a high estimate of $0.07. This represents a 14202.00% increase compared to SGRY previous annual EPS of - (Dec 23).
Surgery Partners Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| SEM | Select Medical | $19.12 | $40.00 | 109.21% | Buy |
| INNV | InnovAge | $4.08 | $6.80 | 66.67% | Hold |
| SGRY | Surgery Partners | $21.03 | $35.00 | 66.43% | Buy |
| UHS | Universal Health Services | $182.60 | $249.67 | 36.73% | Hold |
| PNTG | Pennant Group | $29.21 | $34.67 | 18.69% | Buy |
| HCSG | Healthcare Services Group | $11.80 | $14.00 | 18.64% | Hold |
| EHAB | Enhabit | $8.29 | $9.50 | 14.60% | Hold |
| ENSG | Ensign Group | $140.00 | $159.00 | 13.57% | Buy |
| ADUS | Addus HomeCare | $130.73 | $146.20 | 11.83% | Buy |
| EHC | Encompass Health | $96.94 | $107.50 | 10.89% | Buy |